On November 14th of this year, the FDA cleared the path for Upside Foods to sell its cell-culture-based chicken products within the US. This is the first product of its kind to be cleared for commercial sale within the Americas, with only Singapore having previously cleared a similar product for sale, back in December of 2020. This latter product comes courtesy of another California start-up called Eat Just.
Since that initial approval in Singapore, Eat Just has begun to set up a 2,800 square meter (~30,000 square feet) production facility in Singapore that is scheduled to begin producing thousands of kilograms of slaughter-free meat starting in the first quarter of 2023. This would make it the top-runner in the cultured meat industry, which to this point has seen dozens of start-ups, but precious few actual products for sale.
With CEO Josh Tetrick of Eat Just projecting price equality between their cultured meat and meat from animals by 2030, could the FDA’s approval herald the dawn of slaughter-free meat? There are obviously still hurdles, but as we’ll see, the idea is not nearly as far-fetched as one might think.
